caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1225136047

Anne BatesN.P.P.

PRACTICEGENOA HEALTHCARE LLCSee all providers at this practice →
Nurse PractitionerValparaiso, INI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Anne Bates's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PORTER HOSPITAL LLC1644
PORTER-STARKE SERVICES INC1352
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
PORTER-STARKE SERVICES INC53161
PORTER HOSPITAL LLC1140
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
38
Unique beneficiaries
—
Total services
165
Distinct HCPCS
3
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 5,912 Nurse Practitioner providers in IN — below median (cohort median 287).
PRESCRIBING · PART D · 2024
Total Rx claims
1,194
Beneficiaries
—
Total drug cost
$175K
Distinct drugs
34
Brand share
17.2%
Top prescribed drugs
Quetiapine Fumarate97 claims
Olanzapine80 claims
Venlafaxine Hcl74 claims
Trazodone Hcl71 claims
Fluoxetine Hcl63 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.